Figure 1. The (a) anterior–posterior and (b) right-lateral fields and (c, d) the isodose distributions of two axial planes in one patient with T2 stage.

Slides:



Advertisements
Similar presentations
Management of locally advanced & metastatic prostate cancer Dr. Purvish. M. Parikh MD, DNB, PhD, FICP Professor & Head Department of Medical Oncology Tata.
Advertisements

Uro-symphyseal fistulation after prostatic irradiation – an unrecognised but important complication Introduction Chronic pain following external beam radiotherapy.
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):
Treatment Techniques for the Pelvis Region - Prostate - (- Cervix Ca -) Uwe Götz, Bernd Schicker Institute of Radiation Oncology Limburg, Germany Treatment.
H Ariyaratne1,2, H Chesham2, J Pettingell2, K Sikora2, R Alonzi1,2
Training Module 3 – Version 1.1 For Internal Use Only ® Radiation Therapy 
PROSTATE CANCER: RADIATION THERAPY APPROACHES ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT.
1 ASCO Annual Meeting 2013 Poster presentation January 2013.
Introduction/Aims There is less written about failure patterns after prostate brachytherapy (BT) alone or in combination with external beam radiotherapy.
Outcome of patients treated with Image Guided Brachytherapy for Locally Advanced Carcinoma of the Cervix at Royal Devon & Exeter Hospital Dr.
Patient and Tumour Characteristics Median age 60 years (26-92) Karnofsky Status:median 90 (50-100) Histology:SCC: n=120 (83%) Tumor size: ≥ 5 cm: n=78.
Does my bum look big in this? Audit of rectal volumes and AP diameter in planning scans for radical prostate radiotherapy Tse V, Lorimer CFK, Parker R,
Image Guided Interstitial Brachytherapy For Locally Advanced Gynaecological Cancer With A MUPIT Applicator M.A.D. Haverkort, MD 1, E. Van der Steen - Banasik,
방사선종양학과 - 혈액종양내과 Joint Conference 경희의료원 방사선종양학과 R4 공 문 규.
Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.
Modern Radiation Oncology
Fig. 1 Frequency distribution of initial palliative treatment modalities used. EBRT, external beam radiotherapy. Initial palliative treatment modality.
Figure 1. Scree plot for the exploratory factor analysis (EFA) of the Death Depression Scale (DDS). From: Development and psychometric evaluation of a.
Bladder Cancer and Prostatic Cancer
Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin.
Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.
Table 1 Symptoms and signs at presentation
Figure 2. (A) Sézary syndrome patient before treatment
Figure 2. Kaplan–Meier survival analysis in patients
بسم الله الرحمن الرحيم ﴿و قل رب زدنى علماً﴾ صدق الله العظيم.
Figure 1. Prevalence of undocumented hepatitis C virus (HCV) infection, by age, race, and sex in 4713 emergency department patients, From: Evaluation.
Figure 1. Overall survival of patients receiving alternative medicine (solid lines) vs conventional cancer treatment (dashed lines). Overall survival of.
Fig. 1 Flow diagram of patient selection and study design.
Figure 1: Time points at which sperm samples were analysed for aneuploidy frequencies in controls and cancer patients From: Sperm aneuploidy frequencies.
Figure 1. (a) Dose distribution of dynamic conformal photon therapy
Figure 1. Example of phase shift angles among three different terns where one of them has been taken as a reference. From: Assessment of ELF magnetic fields.
Figure 1. Progression-free survival and overall survival for FL/DLBCL patients. From: Clinicobiological features and prognostic impact of diffuse large.
Figure 1. Cellular distribution of a disintegrin and metalloproteinases (ADAM)-9 expression in hepatocellular carcinoma (HCC) and non-tumorous liver tissues.
RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.
Figure 2 Underreporting by physicians of specific treatment-associated symptoms by physicians in the TORCH trial Figure 2 | Underreporting by physicians.
Figure 1. Patterns of HER2–PET/CT confronted with FDG–PET/CT, Maximum intensity projection. Lesion uptake was considered pertinent when visually higher.
Fig. 1 Languages used for SA
Conformal Photon-Beam Radiotherapy of Prostate Carcinoma
Insert tables Insert graphs Insert figure
Volume 72, Issue 5, Pages (November 2017)
Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.
Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.
What is New in Hormone Therapy for Prostate Cancer in 2007?
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
chemotherapy for patients with MC versus those with AC
Thomas M. Pisansky, MD, Douglas G. Gold, MD, PhD, Keith M
Figure 4 Treatment plans using stereotactic body radiotherapy (SBRT)
Figure 3 Summary of overall survival by Kaplan–Meier
Figure 3 Clinical trial design in charged-particle therapy (CPT)
Figure 1. Non-biochemical recurrence rate for the entire population (n = 122). From: Salvage radiation therapy for prostate cancer patients after prostatectomy.
Figure 1 Comparison of LDR‑BT, HDR‑BT, and EBRT
Physics and Imaging in Radiation Oncology
Neoadjuvant Adjuvant Curative Palliative
Figure 2 Variations between planned and delivered doses of radiation
Changes in apparent diffusion coefficient radiomics features during dose-painted radiotherapy and high dose rate brachytherapy for prostate cancer  Sangjune.
Figure 2 The evolution of brachytherapy for prostate cancer
Technical Advances of Radiation Therapy for Thymic Malignancies
Figure 1 Data-selection process
Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance.
Volume 53, Issue 6, Pages (June 2008)
Figure 1. Relationships among microsatellite instability (MSI; letter A indicates the group with MSI), high tumour ... Figure 1. Relationships among microsatellite.
Management of Prostate Cancer: Global Strategies
Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.
Figure 3 Target volume definitions
Figure 2. Kaplan–Meier curves derived from data generated under study-specific assumptions. (A) Kaplan–Meier curves ... Figure 2. Kaplan–Meier curves derived.
Technical Innovations and Patient Support in Radiation Oncology
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 2. Forest plot of multivariable Cox proportional hazard regression illustrating the impact of chemoradiation ... Figure 2. Forest plot of multivariable.
Figure 1. Forest plot of lung cancer mortality in LDCT trials.
Presentation transcript:

Figure 1. The (a) anterior–posterior and (b) right-lateral fields and (c, d) the isodose distributions of two axial planes in one patient with T2 stage prostate carcinoma irradiated by a rectangular four-field technique. B, Bladder; P, Prostate; R, Rectum; S, Seminal vesicle. From: Comparison of the Outcome and Morbidity for Localized or Locally Advanced Prostate Cancer Treated by High-dose-rate Brachytherapy Plus External Beam Radiotherapy (EBRT) Versus EBRT Alone Jpn J Clin Oncol. 2008;38(7):474-479. doi:10.1093/jjco/hyn056 Jpn J Clin Oncol | © The Author (2008). Published by Oxford University Press. All rights reserved 1